Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
FK-866
As low as
55
CHF
CHF 55.00
In stock
Only %1 left
AG-CR1-0011-M0011 mgCHF 55.00
AG-CR1-0011-M0055 mgCHF 120.00
AG-CR1-0011-M02525 mgCHF 360.00
Specifications / Handling
| Product Details | |
|---|---|
| Synonyms | Daporinad; K 22.175; FK866; APO866; WK175; N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2E-propenamide |
| Product Type | Chemical |
| Properties | |
| Formula |
C24H29N3O2 |
| MW | 391.5 |
| CAS | 658084-64-1 |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | White to off-white powder. |
| Solubility | Soluble in 100% ethanol, dimethylformamide (40 mg/ml) or DMSO (25 mg/ml); sparingly soluble in aqueous buffers. |
| Identity | Determined by 1H-NMR |
| InChi Key | KPBNHDGDUADAGP-VAWYXSNFSA-N |
| Smiles | O=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1 |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Hygroscopic. Keep under inert gas. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Scientific Background Information
Product Description
- Nampt/visfatin inhibitor [1].
- Inhibitor of NAD+ biosynthesis [1].
- Inhibits the enzyme/substrate complex and the free enzyme (Ki = 0.4 nM and Ki = 0.3 nM, respectively) [1].
- Apoptosis inducer [1].
- Autophagy inducer [2].
- Causes premature senescence [3].
- Angiogenesis inhibitor [4].
Product-specific References
- FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis: M. Hasmann & I. Schemainda; Cancer Res. 63, 7436 (2003) [PMID: 14612543]
- NAD depletion by FK866 induces autophagy: R.A. Billington, et al.; Autophagy 4, 385 (2008) [PMID: 18227641]
- Extension of human cell lifespan by nicotinamide phosphoribosyltransferase: E. van der Veer, et al.; J. Biol. Chem. 282, 10841 (2007) [PMID: 17307730]
- Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma: J. Drevs, et al.; Anticancer Res. 23, 4853 (2003) [PMID: 14981935]
Additional References using AdipoGen AG-CR1-0011: - Nutritional Energy Stimulates NAD+ Production to Promote Tankyrase-Mediated PARsylation in Insulinoma Cells: L. Zhong, et al.; PLoS One 10, e0122948 (2015) [PMC4395342]
- Nicotinamide phosphoribosyltransferase production in human spermatozoa is influenced by maturation stage: S. Riammer, et al.; Andrology 4, 1045 (2016) [PMID: 27566659]
- EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells: C.N. Mutz, et al.; Oncotarget 8, 24679 (2017) [PMC5421879]
- Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis: L. Brandl, et al.; Neoplasia 21, 974 (2019) [PMC6710297]
- A peroxisome deficiency–induced reductive cytosol state up-regulates the brain-derived neurotrophic factor pathway: Y. Abe, et al.; J. Biol. Chem. 295, 5321 (2020) [PMC7170515]
- Visfatin Induces Senescence of Human Dental Pulp Cells: C.Y. Ok, et al.; Cells 9, 193 (2020) [PMC7017355]
- FK866 Protects Human Dental Pulp Cells against Oxidative Stress-Induced Cellular Senescence: C.Y. Ok, et al.; Antioxidants 10, 271 (2021) [PMC7916510]
- Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells: Y. Sasaki, et al.; PLoS One 19, e0302130 (2024) [PMC11020856]
- Human plasma-derived eNAMPT-containing extracellular vesicles promote NAD+ biosynthesis and thermogenesis in mice: K. Yoshioka, et al.; npj Aging 11, 106 (2025) [PMC12749881]